Security key
471871202
Jasper Therapeutics, Inc. - Voting Common Stock (JSPR)
CUSIP: 471871202
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Voting Common Stock
- Total 13F shares
- 13,034,173
- Total 13F value
- $56,047,183
- Share change
- -2,590,135
- Put/Call ratio
- 70%
- SEC-reported price per share
- $4.30
- Number of holders
- 66
- Value change
- -$70,633,595
- Number of buys
- 29
- Number of sells
- 51
- Shares outstanding
- 33,341,578
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
66
Top holders
10
JSPR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 471871202
Recent filing periods:
Ownership snapshot
Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Velan Capital Investment ...
Disclosed value leader
Soleus Capital Management...
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F
3/4/5
Highest disclosed value: $31,950,700
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Soleus Capital Management, L.P. has the largest disclosed position value at $31.95M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Soleus Capital Management, L.P.'s linked filing trail.
Disclosed position value
Top 5
Velan Capital Investment Manageme...
$30.66M
Carlyle Group Inc.
$22.67M
Qiming U.S. Healthcare Fund II, L.P.
$5.53M
ROCHE HOLDING LTD
$2.95M
Amplitude Healthcare Holdings LLC
$1.49M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$30,655,243
1,433,828 shares
|
— | 31 Dec 2024 |
| Carlyle Group Inc. |
13F
3/4/5
Company · Former 10% Owner
|
—
denominator unverified
|
$22,667,178
1,066,189 shares
|
— | 31 Dec 2024 |
| Qiming U.S. Healthcare Fund II, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$5,525,844
8,519,648 shares
|
— | 27 Jan 2023 |
| ROCHE HOLDING LTD |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$2,950,874
4,549,606 shares
|
— | 25 Jan 2023 |
| Amplitude Healthcare Holdings LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,491,780
2,300,000 shares
|
— | 24 Sep 2021 |
| Abingworth LLP |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
78,045 shares
|
— | 21 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
66
Shares
13,034,173
Rows available
66
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
66
Q1 2025 holders
66
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend